Patients with inflammatory bowel disease (IBD) are at increased risk of developing
colorectal cancer (CRC), despite decreases in CRC incidence in recent years. Chronic …

Colorectal cancer (CRC) is the third most common cancer and the fourth most common
cause of cancer-related death. Most cases of CRC are detected in Western countries, with its …

Molecular pathology diagnostics to subclassify diseases based on pathogenesis are
increasingly common in clinical translational medicine. Molecular pathological epidemiology …

The precision medicine concept and the unique disease principle imply that each patient
has unique pathogenic processes resulting from heterogeneous cellular genetic and …

The aim of this study was to identify single nucleotide variants in genes associated with
susceptibility to or severe outcomes of COVID-19. A total of 319 genomic DNA samples from …

Patients with long-standing inflammatory bowel disease (IBD) have an increased risk of
colorectal cancer (CRC). The association between IBD and CRC is well supported, but …

Colitis-associated colorectal cancer (CA-CRC) is the cause of death in 10%-15% of
inflammatory bowel disease (IBD) patients. CA-CRC results from the accumulation of …

Colorectal cancer (CRC) is the third most common cancer worldwide, with high incidence
and mortality rates. Conventional therapies, including surgery, chemotherapy and radiation …

Context There is an inconsistency between the results obtained from observational studies
regarding intake of ultra-processed foods (UPFs) and the risk of inflammatory bowel disease …

Aim: To determine whether single nucleotide polymorphisms (SNPs) can be used to identify
people who should be screened for colorectal cancer. Methods: We simulated one million …